Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii

被引:106
|
作者
Chusri, Sarunyou [1 ,2 ,3 ]
Chongsuvivatwong, Virasakdi [3 ]
Rivera, Jesabel I. [2 ]
Silpapojakul, Kachornsakdi [1 ]
Singkhamanan, Kamonnut [4 ]
McNeil, Edward [3 ]
Doi, Yohei [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Div Infect Dis, Hat Yai, Thailand
[2] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA
[3] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand
[4] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Thailand
基金
美国国家卫生研究院;
关键词
ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BAUMANNII; IDENTIFICATION; BACTEREMIA; EPIDEMIOLOGY; EMERGENCE; TESTS; SPP; GENE;
D O I
10.1128/AAC.02992-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of Acinetobacter nosocomialis and Acinetobacter pittii, which belong to the A. calcoaceticus-A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort study of hospital-acquired A. calcoaceticus-A. baumannii complex infections at a university hospital in Thailand. A total of 222 unique cases were identified between January 2010 and December 2011. The genomospecies of the A. calcoaceticus-A. baumannii complex isolates were classified as follows: A. baumannii, 197 (89%); A. nosocomialis, 18 (8%); and A. pittii, 7 (3%). All A. nosocomialis and A. pittii isolates were susceptible to imipenem and meropenem. The patients infected with A. nosocomialis and A. pittii had lower 30-day mortality than those infected with carbapenem-susceptible A. baumannii (P = 0.025) and carbapenem-resistant A. baumannii (P = 0.013). The factors influencing 30-day mortality were infection with non-baumannii A. calcoaceticus-A. baumannii complex (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.03 to 0.51; P = 0.004), infection with carbapenem-resistant A. baumannii (HR, 1.57; 95% CI, 0.89 to 2.79; P = 0.105), appropriate empirical antimicrobial therapy (HR, 0.38; 95% CI, 0.23 to 0.61; P < 0.001), and higher acute physiology and chronic health evaluation II (APACHE II) score (HR, 1.15; 95% CI, 1.10 to 1.19; P < 0.001). In Galleria mellonella assays, the survival rates were significantly higher for the larvae infected with A. nosocomialis or A. pittii than for those infected with either carbapenem-susceptible A. baumannii or carbapenem-resistant A. baumannii, but no differences in survival rates were observed between carbapenem-susceptible A. baumannii and carbapenem-resistant A. baumannii. These findings suggest intrinsic differences in virulence between non-baumannii A. calcoaceticus-A. baumannii complex species and A. baumannii but not between carbapenem-susceptible and resistant A. baumannii.
引用
收藏
页码:4172 / 4179
页数:8
相关论文
共 50 条
  • [1] Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis
    Liu, Yuag-Meng
    Lee, Yi-Tzu
    Kuo, Shu-Chen
    Chen, Te-Li
    Liu, Chang-Pan
    Liu, Chun-Eng
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (01) : 62 - 67
  • [2] Rapid identification of Acinetobacter baumannii, Acinetobacter nosocomialis and Acinetobacter pittii with a multiplex PCR assay
    Chen, Te-Li
    Lee, Yi-Tzu
    Kuo, Shu-Chen
    Yang, Su-Pen
    Fung, Chang-Phone
    Lee, Shou-Dong
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 1154 - 1159
  • [3] Acinetobacter pittii: the emergence of a hospital-acquired pathogen analyzed from the genomic perspective
    Bello-Lopez, Elena
    Escobedo-Munoz, Ana Sofia
    Guerrero, Gabriela
    Cruz-Cordova, Ariadnna
    Garza-Gonzalez, Elvira
    Hernandez-Castro, Rigoberto
    Zarain, Patricia Lozano
    Morfin-Otero, Rayo
    Volkow, Patricia
    Xicohtencatl-Cortes, Juan
    Cevallos, Miguel A.
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [4] Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China
    Wang, Xiaohui
    Chen, Tao
    Yu, Rujia
    Lu, Xiaoju
    Zong, Zhiyong
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (03) : 392 - 395
  • [5] Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States
    Wisplinghoff, Hilmar
    Paulus, Tobias
    Lugenheim, Marianne
    Stefanik, Danuta
    Higgins, Paul G.
    Edmond, Michael B.
    Wenzel, Richard P.
    Seifert, Harald
    JOURNAL OF INFECTION, 2012, 64 (03) : 282 - 290
  • [6] Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia
    Chusri, Sarunyou
    Chongsuvivatwong, Virasakdi
    Silpapojakul, Kachornsakdi
    Singkhamanan, Kamonnut
    Hortiwakul, Thanaporn
    Charernmak, Boonsri
    Doi, Yohei
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (05) : 796 - 806
  • [7] Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand
    Singkham-in, Uthaibhorn
    Chatsuwan, Tanittha
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (12) : 1667 - 1672
  • [8] Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital
    Ayan, M
    Durmaz, R
    Aktas, E
    Durmaz, B
    JOURNAL OF HOSPITAL INFECTION, 2003, 54 (01) : 39 - 45
  • [9] HOSPITAL-ACQUIRED ACINETOBACTER BAUMANII PNEUMONITIS
    YGOUT, JF
    HOUSSET, B
    DERENNE, JP
    DAGUET, GL
    LANCET, 1987, 1 (8536): : 802 - 802
  • [10] HOSPITAL-ACQUIRED INFECTION OF ACINETOBACTER BAUMANNII IN CHILDREN ADMITTED TO THE ICU
    Kim, Beomjoon
    Bae, Woori
    Kim, Kyunghoon
    Lee, Hye Jin
    Yoon, Jong-Seo
    CRITICAL CARE MEDICINE, 2019, 47